129 related articles for article (PubMed ID: 16546729)
1. [Antigenicity analysis of nucleocapsid proteins of 3 human coronaviruses SARS-CoV, 229E and OC43 with their monoclonal antibodies].
Qiu LW; Wang YD; Liao ZY; Wen K; Che XY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):290-3. PubMed ID: 16546729
[TBL] [Abstract][Full Text] [Related]
2. Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43.
Lee HK; Lee BH; Seok SH; Baek MW; Lee HY; Kim DJ; Na YR; Noh KJ; Park SH; Kumar DN; Kariwa H; Nakauchi M; Heo SJ; Park JH
J Vet Sci; 2010 Jun; 11(2):165-7. PubMed ID: 20458159
[TBL] [Abstract][Full Text] [Related]
3. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.
Che XY; Qiu LW; Liao ZY; Wang YD; Wen K; Pan YX; Hao W; Mei YB; Cheng VC; Yuen KY
J Infect Dis; 2005 Jun; 191(12):2033-7. PubMed ID: 15897988
[TBL] [Abstract][Full Text] [Related]
4. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
[TBL] [Abstract][Full Text] [Related]
5. Characterization and epitope mapping of monoclonal antibodies to the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
Kariwa H; Noda H; Nakauchi M; Ishizuka M; Hashiguchi K; Hashimoto S; Yoshii K; Asano A; Agui T; Kogaki H; Kurano Y; Uchida Y; Fujii N; Okada M; Takashima I
Jpn J Vet Res; 2008 Feb; 55(4):115-27. PubMed ID: 18380153
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies.
Sastre P; Dijkman R; Camuñas A; Ruiz T; Jebbink MF; van der Hoek L; Vela C; Rueda P
Clin Vaccine Immunol; 2011 Jan; 18(1):113-8. PubMed ID: 21084464
[TBL] [Abstract][Full Text] [Related]
7. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63.
Chan KH; Cheng VC; Woo PC; Lau SK; Poon LL; Guan Y; Seto WH; Yuen KY; Peiris JS
Clin Diagn Lab Immunol; 2005 Nov; 12(11):1317-21. PubMed ID: 16275947
[TBL] [Abstract][Full Text] [Related]
8. [Development and application of triple antibodies-based sandwich ELISA for detecting nucleocapsid protein of SARS-associated coronavirus].
Qiu LW; Tang HW; Wang YD; Liao JE; Hao W; Wen K; He XM; Che XY
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):277-81. PubMed ID: 15941537
[TBL] [Abstract][Full Text] [Related]
9. SARS coronavirus nucleocapsid protein monoclonal antibodies developed using a prokaryotic expressed protein.
Zhang J; Wang D; Li Y; Zhao Q; Huang A; Zheng J; Chen W
Hybridoma (Larchmt); 2011 Oct; 30(5):481-5. PubMed ID: 22008077
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein.
Wen K; Mei YB; Qiu LW; Liao ZY; Yuen KY; Che XY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):1-6. PubMed ID: 14724082
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
Tamminen K; Salminen M; Blazevic V
Clin Immunol; 2021 Aug; 229():108782. PubMed ID: 34118402
[TBL] [Abstract][Full Text] [Related]
12. Development, characterization, and application of monoclonal antibodies against severe acute respiratory syndrome coronavirus nucleocapsid protein.
Das D; Kammila S; Suresh MR
Clin Vaccine Immunol; 2010 Dec; 17(12):2033-6. PubMed ID: 20926700
[TBL] [Abstract][Full Text] [Related]
13. Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43.
Blanchard EG; Miao C; Haupt TE; Anderson LJ; Haynes LM
J Virol Methods; 2011 Oct; 177(1):100-6. PubMed ID: 21801752
[TBL] [Abstract][Full Text] [Related]
14. The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus.
Mu F; Niu D; Mu J; He B; Han W; Fan B; Huang S; Qiu Y; You B; Chen W
BMC Microbiol; 2008 Nov; 8():207. PubMed ID: 19038059
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
Zheng Z; Monteil VM; Maurer-Stroh S; Yew CW; Leong C; Mohd-Ismail NK; Cheyyatraivendran Arularasu S; Chow VTK; Lin RTP; Mirazimi A; Hong W; Tan YJ
Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700671
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection.
Liang FY; Lin LC; Ying TH; Yao CW; Tang TK; Chen YW; Hou MH
J Virol Methods; 2013 Feb; 187(2):413-20. PubMed ID: 23174159
[TBL] [Abstract][Full Text] [Related]
18. Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development.
Holenya P; Lange PJ; Reimer U; Woltersdorf W; Panterodt T; Glas M; Wasner M; Eckey M; Drosch M; Hollidt JM; Naumann M; Kern F; Wenschuh H; Lange R; Schnatbaum K; Bier FF
Eur J Immunol; 2021 Jul; 51(7):1839-1849. PubMed ID: 33772767
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and characterization of monoclonal antibodies against SARS-associated coronavirus nucleocapsid protein].
Wang YB; Chang ZR; Wang JW; Ji R; Han CH; Zhao L; Ren LL; Chao YG; Qu JG; Qu CY; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):316-20. PubMed ID: 15650778
[TBL] [Abstract][Full Text] [Related]
20. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2.
Woldemeskel BA; Kwaa AK; Garliss CC; Laeyendecker O; Ray SC; Blankson JN
J Clin Invest; 2020 Dec; 130(12):6631-6638. PubMed ID: 32966269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
